ArticleFrontiers in immunology2026

Retrospective analysis of transarterial chemoembolization or hepatic arterial infusion chemotherapy combined with lenvatinib with or without PD-1 inhibitor as first-line therapy for unresectable hepatocellular carcinoma with high tumor burden: a propensity score-matched study.

Zhenfeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.